Published in J Clin Microbiol on December 01, 1993
Current methods of laboratory diagnosis of Chlamydia trachomatis infections. Clin Microbiol Rev (1997) 4.37
Comparison of three commercially available amplification assays, AMP CT, LCx, and COBAS AMPLICOR, for detection of Chlamydia trachomatis in first-void urine. J Clin Microbiol (1997) 2.71
General practice update: chlamydia infection in women. Br J Gen Pract (1995) 2.22
Detection of Chlamydia trachomatis in male and female urine specimens by using the amplified Chlamydia trachomatis test. J Clin Microbiol (1997) 1.91
Periodic health examination, 1996 update: 2. Screening for chlamydial infections. Canadian Task Force on the Periodic Health Examination. CMAJ (1996) 1.79
Clinic-based evaluation of Clearview Chlamydia MF for detection of Chlamydia trachomatis in vaginal and cervical specimens from women at high risk in China. Sex Transm Infect (2006) 1.34
Decision analysis: point-of-care Chlamydia testing vs. laboratory-based methods. Clin Med Res (2004) 1.32
Comparison of the PACE 2 assay, two amplification assays, and Clearview EIA for detection of Chlamydia trachomatis in female endocervical and urine specimens. J Clin Microbiol (1999) 1.28
Influence of volume of sample processed on detection of Chlamydia trachomatis in urogenital samples by PCR. J Clin Microbiol (1995) 1.15
Prevalence of Chlamydia trachomatis infection among low- and high-risk Filipino women and performance of Chlamydia rapid tests in resource-limited settings. J Clin Microbiol (2007) 1.08
The laboratory diagnosis of Chlamydia trachomatis infections. Can J Infect Dis Med Microbiol (2005) 0.91
Impact of reference standard sensitivity on accuracy of rapid antigen detection assays and a leukocyte esterase dipstick for diagnosis of Chlamydia trachomatis infection in first-void urine specimens from men. J Clin Microbiol (1999) 0.87
Follicular conjunctivitis caused by Chlamydia trachomatis in an infant Saharan population: molecular and clinical diagnosis. Br J Ophthalmol (2003) 0.83
Laboratory methods for detection of Chlamydia trachomatis: survey of laboratories in Washington State. J Clin Microbiol (1997) 0.82
Low prevalence of Chlamydia trachomatis infection in non-urban pregnant women in Vellore, S. India. PLoS One (2012) 0.78
Solid-phase C1q-directed bacterial capture followed by PCR for detection of Chlamydia trachomatis in clinical specimens. J Clin Microbiol (1995) 0.78
Evaluation of Clearview Chlamydia. J Clin Microbiol (1994) 0.75
Guidelines for cultivation and preservation of the serum-free cell line McCoy-Plovdiv. Cytotechnology (2003) 0.75
Diagnosis of Chlamydia trachomatis genitourinary infections. Ann Intern Med (1988) 6.25
Laboratory diagnosis of human chlamydial infections. Clin Microbiol Rev (1989) 4.24
Use of polymerase chain reaction for detection of Chlamydia trachomatis. J Clin Microbiol (1990) 3.83
Diagnosis of Chlamydia trachomatis cervical infection by detection of amplified DNA with an enzyme immunoassay. J Clin Microbiol (1990) 3.80
Effect of swab type and storage temperature on the isolation of Chlamydia trachomatis from clinical specimens. J Clin Microbiol (1985) 3.29
Diagnostic value of the polymerase chain reaction for Chlamydia detection as determined in a follow-up study. J Clin Microbiol (1991) 3.27
Development and clinical evaluation of a polymerase chain reaction test for detection of Chlamydia trachomatis. J Clin Microbiol (1992) 3.01
Detection of Chlamydia trachomatis in clinical specimens by the polymerase chain reaction. Eur J Clin Microbiol Infect Dis (1990) 2.86
Characterization and sequence of a plasmid from the trachoma biovar of Chlamydia trachomatis. Plasmid (1987) 2.26
Performance of a nonisotopic DNA probe for detection of Chlamydia trachomatis in urogenital specimens. J Clin Microbiol (1991) 2.21
Serovar distribution of urogenital Chlamydia trachomatis strains in The Netherlands. Genitourin Med (1988) 2.07
Evaluation of the rapid CLEARVIEW Chlamydia test for direct detection of chlamydiae from cervical specimens. J Clin Microbiol (1991) 1.80
Evaluation of culture and the Gen-Probe PACE 2 assay for detection of Neisseria gonorrhoeae and Chlamydia trachomatis in endocervical specimens transported to a state health laboratory. J Clin Microbiol (1992) 1.76
Survival of Chlamydia trachomatis in different transport media and at different temperatures: diagnostic implications. Br J Vener Dis (1984) 1.59
Comparison of HeLa 229 and McCoy cell cultures for detection of Chlamydia trachomatis in clinical specimens. J Clin Microbiol (1989) 1.56
Evaluation of a novel solid-phase immunoassay, Clearview Chlamydia, for the rapid detection of Chlamydia trachomatis. J Clin Microbiol (1990) 1.51
Comparison of the Gen-Probe PACE 2 system, direct fluorescent-antibody, and cell culture for detecting Chlamydia trachomatis in cervical specimens. Am J Clin Pathol (1991) 1.49
Comparison of the Clearview Chlamydia test, Chlamydiazyme, and cell culture for detection of Chlamydia trachomatis in women with a low prevalence of infection. J Clin Microbiol (1991) 1.27
Preliminary evaluation of "Clearview Chlamydia" for the rapid detection of chlamydial antigen in cervical secretions. Genitourin Med (1991) 1.24
Genital Chlamydia infections. Clin Lab Med (1989) 1.16
Evaluation of a nonisotopic probe for detection of Chlamydia trachomatis in endocervical specimens. J Clin Microbiol (1990) 1.15
Comparison of chemiluminescent DNA probe to cell culture for the screening of Chlamydia trachomatis in a gynecology clinic population. Obstet Gynecol (1990) 1.08
Enhancement of yield of Chlamydia trachomatis Hela 229 cell culture. Eur J Clin Microbiol Infect Dis (1988) 1.07
Evaluation of an enzyme immunoassay for detection of Chlamydia trachomatis in urogenital specimens. Int J STD AIDS (1990) 1.04
A comparison of three rapid chlamydial tests in pregnant and nonpregnant women. J Fam Pract (1992) 1.01
Evaluation of a chemiluminometric immunoassay and a direct immunofluorescence test for detecting Chlamydia trachomatis in urogenital specimens. Eur J Clin Microbiol Infect Dis (1991) 0.83
Evaluation of a new chemiluminometric immunoassay, Magic Lite Chlamydia, for detecting Chlamydia trachomatis antigen from urogenital specimens. Sex Transm Dis (1992) 0.83
Comparison of phage typing and DNA fingerprinting by polymerase chain reaction for discrimination of methicillin-resistant Staphylococcus aureus strains. J Clin Microbiol (1993) 3.40
Geographic distribution of vacA allelic types of Helicobacter pylori. Gastroenterology (1999) 3.37
Diagnostic value of the polymerase chain reaction for Chlamydia detection as determined in a follow-up study. J Clin Microbiol (1991) 3.27
Genus- and species-specific identification of mycoplasmas by 16S rRNA amplification. Appl Environ Microbiol (1992) 3.05
Comprehensive study of several general and type-specific primer pairs for detection of human papillomavirus DNA by PCR in paraffin-embedded cervical carcinomas. J Clin Microbiol (1996) 2.94
Lamivudine resistance in immunocompetent chronic hepatitis B. Incidence and patterns. J Hepatol (1997) 2.86
Detection of Chlamydia trachomatis in clinical specimens by the polymerase chain reaction. Eur J Clin Microbiol Infect Dis (1990) 2.86
Concordant clonal delineation of methicillin-resistant Staphylococcus aureus by macrorestriction analysis and polymerase chain reaction genome fingerprinting. J Clin Microbiol (1993) 2.79
Typing of Helicobacter pylori vacA gene and detection of cagA gene by PCR and reverse hybridization. J Clin Microbiol (1998) 2.77
Expanding allelic diversity of Helicobacter pylori vacA. J Clin Microbiol (1998) 2.73
Comparison of three commercially available amplification assays, AMP CT, LCx, and COBAS AMPLICOR, for detection of Chlamydia trachomatis in first-void urine. J Clin Microbiol (1997) 2.71
Rapid, polymerase chain reaction-based identification assays for Candida species. J Clin Microbiol (1993) 2.70
Nasal carriage of Staphylococcus aureus as a major risk factor for wound infections after cardiac surgery. J Infect Dis (1995) 2.69
EUCAST expert rules in antimicrobial susceptibility testing. Clin Microbiol Infect (2011) 2.65
Infectious RNA transcripts from Ross River virus cDNA clones and the construction and characterization of defined chimeras with Sindbis virus. Virology (1991) 2.57
Colorimetric assay for antifungal susceptibility testing of Aspergillus species. J Clin Microbiol (2001) 2.53
Detection of PCR inhibitors in cervical specimens by using the AMPLICOR Chlamydia trachomatis assay. J Clin Microbiol (1996) 2.52
Detection of Mycoplasma pneumoniae by two polymerase chain reactions and role of M. pneumoniae in acute respiratory tract infections in pediatric patients. J Infect Dis (1996) 2.51
Cigarette smoking and human papillomavirus in patients with reported cervical cytological abnormality. BMJ (1993) 2.50
Evaluation of an enzyme immunoassay for the diagnosis of chlamydial infections in urogenital specimens. J Clin Microbiol (1986) 2.44
Rapid detection of methicillin resistance in Staphylococcus aureus isolates by the MRSA-screen latex agglutination test. J Clin Microbiol (1999) 2.40
Identification of Burkholderia spp. in the clinical microbiology laboratory: comparison of conventional and molecular methods. J Clin Microbiol (1999) 2.36
Sensitivity to ampicillin, penicillin, and tetracyline of gonococci in Rotterdam. Br J Vener Dis (1974) 2.31
Type-specific identification of influenza viruses A, B and C by the polymerase chain reaction. J Virol Methods (1992) 2.25
Recanalization after intravenous thrombolysis: does a recanalization time window exist? Neurology (2007) 2.23
Performance of a nonisotopic DNA probe for detection of Chlamydia trachomatis in urogenital specimens. J Clin Microbiol (1991) 2.21
Reliability of methods for hepatitis B virus DNA detection. J Clin Microbiol (1995) 2.16
Nosocomial colonization and infection with multiresistant Acinetobacter baumannii: outbreak delineation using DNA macrorestriction analysis and PCR-fingerprinting. J Hosp Infect (1993) 2.12
Development of a quantitative real-time detection assay for hepatitis B virus DNA and comparison with two commercial assays. J Clin Microbiol (2000) 2.11
Safety of modified vaccinia virus Ankara (MVA) in immune-suppressed macaques. Vaccine (2001) 2.06
Molecular epidemiology of drug-resistant pneumococci: toward an international approach. Microb Drug Resist (1997) 2.03
Prevalence of human papillomavirus DNA in different histological subtypes of cervical adenocarcinoma. Am J Pathol (2000) 1.97
Use of anticontamination primers in the polymerase chain reaction for the detection of human papilloma virus genotypes in cervical scrapes and biopsies. J Med Virol (1989) 1.95
Detection of Neisseria gonorrhoeae antigen by a solid-phase enzyme immunoassay. Br J Vener Dis (1982) 1.94
Improved detection of Candida albicans by PCR in blood of neutropenic mice with systemic candidiasis. J Clin Microbiol (1995) 1.93
Detection of Chlamydia trachomatis in male and female urine specimens by using the amplified Chlamydia trachomatis test. J Clin Microbiol (1997) 1.91
[A penicillinase forming strain of gonococcus isolated in Rotterdam]. Ned Tijdschr Geneeskd (1977) 1.89
Rising incidence of chancroid in Rotterdam. Epidemiological, clinical, diagnostic, and therapeutic aspects. Br J Vener Dis (1979) 1.87
Activity of eight antimicrobial agents in vitro against N. Gonorrhoeae. Br J Vener Dis (1975) 1.84
Factors influencing detection of tolerance in Staphylococcus aureus. Antimicrob Agents Chemother (1982) 1.77
Rapid and sensitive detection of Campylobacter spp. in chicken products by using the polymerase chain reaction. Appl Environ Microbiol (1992) 1.77
Comparison of NCCLS and 3-(4,5-dimethyl-2-Thiazyl)-2, 5-diphenyl-2H-tetrazolium bromide (MTT) methods of in vitro susceptibility testing of filamentous fungi and development of a new simplified method. J Clin Microbiol (2000) 1.76
Regional distribution and incidence of human papillomavirus infections among heterosexual men and women with multiple sexual partners: a prospective study. Genitourin Med (1994) 1.73
Human papillomavirus detection in urine samples from male patients by the polymerase chain reaction. J Clin Microbiol (1989) 1.72
Reduction of surgical-site infections in cardiothoracic surgery by elimination of nasal carriage of Staphylococcus aureus. Infect Control Hosp Epidemiol (1996) 1.72
Analysis of growth characteristics of filamentous fungi in different nutrient media. J Clin Microbiol (2001) 1.68
Detection and typing of human papillomavirus DNA in penile carcinoma: evidence for multiple independent pathways of penile carcinogenesis. Am J Pathol (2001) 1.67
Development of species-specific DNA probes for Campylobacter jejuni, Campylobacter coli, and Campylobacter lari by polymerase chain reaction fingerprinting. J Clin Microbiol (1993) 1.67
Phylogeny of antigenic variants of avian coronavirus IBV. Virology (1989) 1.65
[Turning white overnight, is it possible?]. Ned Tijdschr Geneeskd (1993) 1.61
In vitro interaction of terbinafine with itraconazole against clinical isolates of Scedosporium prolificans. Antimicrob Agents Chemother (2000) 1.61
Accurate prediction of macrolide resistance in Helicobacter pylori by a PCR line probe assay for detection of mutations in the 23S rRNA gene: multicenter validation study. Antimicrob Agents Chemother (2001) 1.60
Lipoedema: from clinical presentation to therapy. A review of the literature. Br J Dermatol (2009) 1.60
Antibiotic sensitivities of gonococci isolated in Rotterdam and results of treatment with cefuroxime. Br J Vener Dis (1980) 1.60
Survival of Chlamydia trachomatis in different transport media and at different temperatures: diagnostic implications. Br J Vener Dis (1984) 1.59
Noninvasive quantification of brain edema and the space-occupying effect in rat stroke models using magnetic resonance imaging. Stroke (2004) 1.59
Genotyping Naegleria spp. and Naegleria fowleri isolates by interrepeat polymerase chain reaction. J Clin Microbiol (1992) 1.58
Susceptibility to various antimicrobial agents and tolerance to methicillin of Staphylococcus aureus isolates from cystic fibrosis patients. Eur J Clin Microbiol Infect Dis (1991) 1.57
Comparison of HeLa 229 and McCoy cell cultures for detection of Chlamydia trachomatis in clinical specimens. J Clin Microbiol (1989) 1.56
Gonorrhea in Rotterdam caused by penicillinase-producing gonococci. Br J Vener Dis (1980) 1.55
Human papillomavirus detection in paraffin-embedded cervical carcinomas and metastases of the carcinomas by the polymerase chain reaction. Am J Pathol (1989) 1.53
The localisation of treponemes and characterisation of the inflammatory infiltrate in skin biopsies from patients with primary or secondary syphilis, or early infectious yaws. Genitourin Med (1993) 1.53
Helicobacter pylori genotypes may determine gastric histopathology. Am J Pathol (2001) 1.51
Typing of Aspergillus species and Aspergillus fumigatus isolates by interrepeat polymerase chain reaction. J Clin Microbiol (1993) 1.49
tetM- and beta-lactamase-containing Neisseria gonorrhoeae (tetracycline resistant and penicillinase producing) in The Netherlands. Antimicrob Agents Chemother (1988) 1.48
Comparative double-blind study of 200- and 400-mg enoxacin given orally in the treatment of acute uncomplicated urethral gonorrhea in males. Antimicrob Agents Chemother (1987) 1.47
Decreased mortality rate and length of hospital stay in surgical intensive care unit patients with successful selective decontamination of the gut. Crit Care Med (1993) 1.46
European Committee on Antimicrobial Susceptibility Testing (EUCAST) Technical Notes on antimicrobial susceptibility testing. Clin Microbiol Infect (2006) 1.45
Non-von Recklinghausen's neurofibromatosis resembling a giant pigmented nevus. J Am Acad Dermatol (1989) 1.44
Patient-to-patient spread of a single strain of Corynebacterium striatum causing infections in a surgical intensive care unit. J Clin Microbiol (1996) 1.44
Distinct variants of Helicobacter pylori cagA are associated with vacA subtypes. J Clin Microbiol (1999) 1.43
Sensitivity of in situ detection with biotinylated probes of human papilloma virus type 16 DNA in frozen tissue sections of squamous cell carcinomas of the cervix. Am J Pathol (1988) 1.43
The TNF-alpha system in heart failure and after heart transplantation: plasma protein levels, mRNA expression, soluble receptors and plasma buffer capacity. Eur Heart J (1999) 1.42
Acute hepatitis C infection: an indication for alfa interferon therapy? Neth J Med (2000) 1.42
International collaborative study on the second EUROHEP HCV-RNA reference panel. J Virol Methods (1996) 1.41